Neurocrine Biosciences Inc
(NAS:NBIX)
$
152.81
0.24 (0.16%)
Market Cap: 15.43 Bil
Enterprise Value: 14.65 Bil
PE Ratio: 46.17
PB Ratio: 6.14
GF Score: 93/100 - Q2 2024 Neurocrine Biosciences Inc Earnings Call TranscriptAug 01, 2024$153.15 (+8.18%)Earnings
- Q1 2024 Neurocrine Biosciences Inc Earnings Call TranscriptMay 01, 2024$143.03 (+3.99%)Earnings
- Q4 2023 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 07, 2024$136.29 (-4.67%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Neurocrine Biosciences Inc To Host Analyst Day TranscriptDec 05, 2023
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 14, 2023
- Q3 2023 Neurocrine Biosciences Inc Earnings Call TranscriptOct 31, 2023$110.94 (+3.56%)Earnings
- Neurocrine Biosciences Inc To Report Crinecerfont PhIII Congenital Adrenal Hyperplasia Results TranscriptOct 05, 2023
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Neurocrine Biosciences Inc at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Neurocrine Biosciences Inc Earnings Call TranscriptAug 01, 2023$103.44 (+1.52%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Neurocrine Biosciences Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 Neurocrine Biosciences Inc Earnings Call TranscriptMay 03, 2023$98.62 (-4.67%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2023
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Neurocrine Biosciences Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 14, 2023
- Q4 2022 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 06, 2023$105.02 (-4.55%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Voyager Therapeutics Inc To Discuss Strategic Collaboration With Neurocrine Biosciences Inc Call TranscriptJan 09, 2023
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 01, 2022
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 15, 2022
- Q3 2022 Neurocrine Biosciences Inc Earnings Call TranscriptNov 01, 2022$119.36 (+3.68%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 Neurocrine Biosciences Inc Earnings Call TranscriptAug 04, 2022$95.93 (+1.99%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Neurocrine Biosciences Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Neurocrine Biosciences Inc Earnings Call TranscriptMay 04, 2022$88.4 (-0.34%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Days (Virtual) TranscriptMar 28, 2022
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- Neurocrine Biosciences Inc at Needham Neuroscience Forum (Virtual) TranscriptMar 16, 2022
- Neurocrine Biosciences Inc at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 11, 2022$85.53 (+7.45%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Sosei Group Corp to Discuss Newly Announced Collaboration with Neurocrine Biosciences Investor Briefing TranscriptNov 23, 2021
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 Neurocrine Biosciences Inc Earnings Call TranscriptNov 01, 2021$106.22 (+0.77%)Earnings
- Neurocrine Biosciences Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 15, 2021
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Neurocrine Biosciences Inc Earnings Call TranscriptAug 03, 2021$97.7 (+1.87%)Earnings
- Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) TranscriptJul 15, 2021
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Neurocrine Biosciences Inc at RBC Capital Markets Global Healthcare Conference (Virtual) TranscriptMay 18, 2021
- Neurocrine Biosciences Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 11, 2021
- Q1 2021 Neurocrine Biosciences Inc Earnings Call TranscriptMay 05, 2021$91.6 (+0.11%)Earnings
- Neurocrine Biosciences Inc at Stifel CNS Day TranscriptApr 01, 2021
- Neurocrine Biosciences Inc at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 16, 2021
- Neurocrine Biosciences Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 04, 2021$114.55 (+1.66%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Neurocrine Biosciences Inc at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- Neurocrine Biosciences Inc at Piper Sandler Healthcare Conference (Virtual) - Pre-recorded Fireside Chat TranscriptNov 23, 2020
- Neurocrine Biosciences Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- Neurocrine Biosciences Inc at Stifel Virtual Healthcare Conference TranscriptNov 16, 2020
- Q3 2020 Neurocrine Biosciences Inc Earnings Call TranscriptNov 09, 2020$102.81 (+6.72%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Neurocrine Biosciences Inc at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2020
- Neurocrine Biosciences Inc at William Blair Biotech Focus Conference (Virtual) TranscriptAug 06, 2020
- Q2 2020 Neurocrine Biosciences Inc Earnings Call TranscriptAug 03, 2020$123.01 (+2.20%)Earnings
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Napa Healthcare Conference (Virtual) TranscriptJun 22, 2020
- Neurocrine Biosciences Inc and Takeda Pharmaceutical Co Ltd Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders TranscriptJun 16, 2020
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- Neurocrine Biosciences Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Neurocrine Biosciences Inc at RBC Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) TranscriptMay 12, 2020
- Q1 2020 Neurocrine Biosciences Inc Earnings Call TranscriptMay 06, 2020$103.48 (+1.67%)Earnings
- Neurocrine Biosciences Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Q4 2019 Neurocrine Biosciences Inc Earnings Call TranscriptFeb 04, 2020$103.1 (+2.64%)Earnings
- Neurocrine Biosciences Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Neurocrine Biosciences Inc at Evercore HealthCONx Conference TranscriptDec 03, 2019
- Xenon Pharmaceuticals Inc. - Special Call TranscriptDec 02, 2019
- Neurocrine Biosciences Inc at Jefferies London Healthcare Conference TranscriptNov 20, 2019
- Neurocrine Biosciences Inc at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Neurocrine Biosciences Inc Earnings Call TranscriptNov 04, 2019$102.42 (-1.20%)Earnings
- Neurocrine Biosciences Inc at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Neurocrine Biosciences Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 Neurocrine Biosciences Inc Earnings Call TranscriptJul 29, 2019$86.97 (-0.58%)Earnings
- Neurocrine Biosciences Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Neurocrine Biosciences Inc at Jefferies Healthcare Conference TranscriptJun 06, 2019
- Neurocrine Biosciences Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Neurocrine Biosciences Inc Earnings Call TranscriptApr 29, 2019$76.77 (-0.84%)Earnings
- Neurocrine Biosciences Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Neurocrine Biosciences Inc at Cowen Health Care Conference TranscriptMar 12, 2019
Neurocrine Biosciences Inc at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021 / 06:30PM GMT
Release Date Price:
$101.42
(-7.32%)
Philip M. Nadeau
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Good afternoon, and welcome once again to Cowen and Company's 41st Healthcare Conference. Hopefully, our only virtual edition. I'm Phil Nadeau, a biotech analyst here at Cowen, and it's my pleasure to moderate a fireside chat with Neurocrine Biosciences. We're really happy to have with us from sunny San Diego, Kevin Gorman, Neurocrine's CEO.
Questions & Answers
Philip M. Nadeau
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Kevin, to kick things off, could you give us a brief state of the company overview, biggest strengths, biggest challenges? And what needs to happen to drive outperformance over the next year?
Kevin C. Gorman
Neurocrine Biosciences, Inc. - CEO & Director
Yes. Thank you, Phil, and thank you, Cowen, for the opportunity to speak here today. I will be making forward-looking statements, so I direct people to our recent SEC filings. Neurocrine is a dyed-in-the-wool
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)